Search Results - karthikeyan+kandavelou

1 Results Sort By:
Improved Obligate Heterodimer FokI Cleavage Domain Variants for Creating Designed Zinc Finger Nucleases with Minimal Cytotoxicity
C11129: Site-specific and Permanent Modification of Genomes with Reduced CytotoxicityNovelty: This technology comprises the generation of re-engineered obligate heterodimer FokI nuclease domain variants to create ZFNs with minimal cell toxicity for targeted modifications in plant, mammalian and even human genomes.Value Proposition: Zinc finger nucleases...
Published: 3/13/2025   |   Inventor(s): Sivaprakash Ramalingam, Karthikeyan Kandavelou, Srinivasan Chandrasegaran
Keywords(s): Drug Delivery Vehicle Synthesis Method, Gene Therapy, Single, Therapeutic Matter, Therapeutics, Therapy Type
Category(s): Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum